Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohammed Alluhidan, Hana Alabdulkarim, Ali Alrumaih, Abdulrahman Al-Turaiki, Abdullah Alshahrani, Saad Al-Qahtani, Abdulaziz Alhossan & Ahmed Al-Jedai. (2023) Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia. Journal of Medical Economics 26:1, pages 1455-1468.
Read now
Read now
Articles from other publishers (21)
Ena Niño-de-Guzmán, Javier Bracchiglione, Adrián Vásquez-Mejía, Gimon de Graaf, Claudio Rocha Calderón & Pablo Alonso-Coello. (2023) How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews. Value in Health 26:12, pages 1782-1794.
Crossref
Crossref
Carlos Alexandre Soares Andrade, Balqees Shahin, Onisoyonivosekume Dede, Anne Omagu Akpeji, Comfort‐Lucia Ajene, Frederico Epalanga Albano Israel & Orsolya Varga. (2023) The burden of type 2 diabetes mellitus in states of the European Union and United Kingdom at the national and subnational levels: A systematic review. Obesity Reviews 24:9.
Crossref
Crossref
Ena Niño-de-Guzman Quispe, Javier Bracchiglione, Marta Ballester, Oliver Groene, Monique Heijmans, Laura Martínez García, Janneke Noordman, Carola Orrego, Claudio Rocha, Rosa Suñol & Pablo Alonso-Coello. (2023) Patients’ and informal caregivers’ perspectives on self-management interventions for type 2 diabetes mellitus outcomes: a mixed-methods overview of 14 years of reviews. Archives of Public Health 81:1.
Crossref
Crossref
Silvia A. G. de Vries, Jessica C. G. Bak, Vincent A. Stangenberger, Michel W. J. M. Wouters, Max Nieuwdorp, Theo C. J. Sas & Carianne L. Verheugt. (2023) Use of hospital care among Dutch diabetes patients. Diabetes, Obesity and Metabolism 25:8, pages 2268-2278.
Crossref
Crossref
Olufemi O Oyewole, Ayotunde O Ale, Michael O Ogunlana & Thavanesi Gurayah. (2023) Burden of disability in type 2 diabetes mellitus and the moderating effects of physical activity. World Journal of Clinical Cases 11:14, pages 3128-3139.
Crossref
Crossref
Hussain A. Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin & Saleh A. Alqahtani. (2023) The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications. Advances in Therapy 40:4, pages 1430-1443.
Crossref
Crossref
Ildiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, Barrie Chubb, Anders Gorst-Rasmussen & Lyndon Marc Evans. (2022) An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes. Diabetes Therapy 14:1, pages 123-137.
Crossref
Crossref
Eva M. Wölfel, Felix N. Schmidt, Annika vom Scheidt, Anna K. Siebels, Birgit Wulff, Herbert Mushumba, Benjamin Ondruschka, Klaus Püschel, Jean Scheijen, Casper G. Schalkwijk, Eik Vettorazzi, Katharina Jähn‐Rickert, Bernd Gludovatz, Eric Schaible, Michael Amling, Martina Rauner, Lorenz C. Hofbauer, Elizabeth A. Zimmermann & Björn Busse. (2022) Dimorphic Mechanisms of Fragility in Diabetes Mellitus: the Role of Reduced Collagen Fibril Deformation. Journal of Bone and Mineral Research 37:11, pages 2259-2276.
Crossref
Crossref
Seung Min Chung, Ji-In Lee, Eugene Han, Hyun-Ae Seo, Eonju Jeon, Hye Soon Kim & Ji Sung Yoon. (2022) Association between the Diabetes Drug Cost and Cardiovascular Events and Death in Korea: A National Health Insurance Service Database Analysis. Endocrinology and Metabolism 37:5, pages 759-769.
Crossref
Crossref
Cornelia Bala, Adriana Rusu, Dana Ciobanu & Gabriela Roman. (2022) Length of Hospital Stay, Hospitalization Costs, and Their Drivers in Adults with Diabetes in the Romanian Public Hospital System. International Journal of Environmental Research and Public Health 19:16, pages 10035.
Crossref
Crossref
Farhad Pourfarzi, Satar Rezaei, Reza Malekzadeh, Arash Etemadi, Telma Zahirian Moghadam & Hamed Zandian. (2022) Socio-economic inequality in prevalence of type 2 diabetes among adults in north-west of Iran: a Blinder-Oaxaca decomposition. Journal of Diabetes & Metabolic Disorders 21:2, pages 1519-1529.
Crossref
Crossref
Dewdunee H. Marasinghe, Sonia Butalia, Stephanie Garies, Neil Drummond, James W. Kim & Peter A. Senior. (2022) Low Use of Guideline-recommended Cardiorenal Protective Antihyperglycemic Agents in Primary Care: A Cross-sectional Study of Adults With Type 2 Diabetes. Canadian Journal of Diabetes 46:5, pages 487-494.
Crossref
Crossref
Kristina S. Boye, Vivian T. Thieu, Maureen J. Lage, Heather Miller & Rosirene Paczkowski. (2022) The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Advances in Therapy 39:5, pages 2208-2221.
Crossref
Crossref
Nimer S. Alkhatib, Abdulaali R. Almutairi, Omar S. Alkhezi, Osama M. Alfayez, Majed S. Al Yami & Omar A. Almohammed. (2022) Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective. Saudi Pharmaceutical Journal 30:4, pages 433-439.
Crossref
Crossref
Marc Evans, Susanne Engberg, Mads Faurby, João Diogo Da Rocha Fernandes, Pollyanna Hudson & William Polonsky. (2021) Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes, Obesity and Metabolism 24:3, pages 377-390.
Crossref
Crossref
Rose J. Geurten, Jeroen N. Struijs, Arianne M. J. Elissen, Henk J. G. Bilo, Chantal van Tilburg & Dirk Ruwaard. (2021) Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016–2018. PharmacoEconomics - Open 6:2, pages 219-229.
Crossref
Crossref
Astrid Coassy, Axel Svedbom, Hervé Locrelle, Roland Chapurlat, Bernard Cortet, Patrice Fardellone, Philippe Orcel, Christian Roux, Fredrik Borgström, John A. Kanis & Thierry Thomas. (2021) Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France—results from the ICUROS study. Osteoporosis International 33:3, pages 625-635.
Crossref
Crossref
Rose J Geurten, Arianne M J Elissen, Henk J G Bilo, Jeroen N Struijs, Chantal van Tilburg & Dirk Ruwaard. (2021) Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures. BMJ Open 11:12, pages e049487.
Crossref
Crossref
José Antonio Gimeno, Gloria Cánovas & Alejandra Durán. (2021) Factors Associated with Adherence to Clinical Practice Guidelines for Patients with Type 2 Diabetes Mellitus: Results of a Spanish Delphi Consensus. Journal of Diabetes Research 2021, pages 1-8.
Crossref
Crossref
Jisang Jung, Min-Gyu Kim, Youn-Joo Kang, Kyungwan Min, Kyung-Ah Han & Hyoseon Choi. (2021) Vibration Perception Threshold and Related Factors for Balance Assessment in Patients with Type 2 Diabetes Mellitus. International Journal of Environmental Research and Public Health 18:11, pages 6046.
Crossref
Crossref
Hai-Yen Nguyen-Thi, Nga TQ. Nguyen, Nguyen Dang Tu Le, Maud Beillat & Olivier Ethgen. (2020) Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam. Frontiers in Public Health 8.
Crossref
Crossref